Cargando…

Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy

NKG2D (natural killer group 2, member D) is an important activating receptor in natural killer (NK) cells and some T cells. NKG2D ligands (NKG2DLs) are specifically expressed on most tumor cells. The engagement of these ligands on tumor cells to NKG2D on NK cells will induce cell-mediated cytotoxici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Hui, Yang, Xi, Wei, Yanzhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796126/ https://www.ncbi.nlm.nih.gov/pubmed/29316666 http://dx.doi.org/10.3390/ijms19010177

Ejemplares similares

New prospects on the NKG2D/NKG2DL system for oncology
por: Ullrich, Evelyn, et al.
Publicado: (2013)

Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer
por: Kaidun, Polina, et al.
Publicado: (2023)

Potential of the NKG2D/NKG2DL Axis in NK Cell-Mediated Clearance of the HIV-1 Reservoir
por: Desimio, Maria G., et al.
Publicado: (2019)

The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
por: Stojanovic, Ana, et al.
Publicado: (2018)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
por: Tan, Ge, et al.
Publicado: (2023)

CD8(+) T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis
por: Lerner, Emily C., et al.
Publicado: (2023)

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
por: Frazao, Alexandra, et al.
Publicado: (2019)

Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in mice
por: Hua, Li, et al.
Publicado: (2016)

Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis
por: Wang, Zhan, et al.
Publicado: (2018)

NKG2D(+)CD4(+) T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
por: Yang, Di, et al.
Publicado: (2017)

Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-γ to modulate antitumor T-cell response after cryo-thermal therapy
por: Peng, Peng, et al.
Publicado: (2022)

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas
por: Hagelstein, Ilona, et al.
Publicado: (2021)

The Role of NKG2D in Vitiligo
por: Plaza-Rojas, Lourdes, et al.
Publicado: (2021)

Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
por: Märklin, Melanie, et al.
Publicado: (2019)

How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
por: Antonangeli, Fabrizio, et al.
Publicado: (2017)

The Paradoxical Role of NKG2D in Cancer Immunity
por: Sheppard, Sam, et al.
Publicado: (2018)

Corrigendum: The Role of NKG2D in Vitiligo
por: Plaza-Rojas, Lourdes, et al.
Publicado: (2021)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
por: Murad, Shafiq, et al.
Publicado: (2022)

Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
por: Zöller, Tobias, et al.
Publicado: (2018)

Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy
por: Ghasemi, Reza, et al.
Publicado: (2016)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

Soluble NKG2D ligands impair CD8(+) T cell antitumor function dependent of NKG2D downregulation in neuroblastoma
por: Zhang, Yi, et al.
Publicado: (2023)

The Latest Breakthroughs in Immunotherapy for Acute Myeloid Leukemia, with a Special Focus on NKG2D Ligands
por: Maurer, Stefanie, et al.
Publicado: (2022)

NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer
por: Smyth, Mark J., et al.
Publicado: (2004)

NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy
por: Cazzetta, Valentina, et al.
Publicado: (2023)

Molecular Bases for the Regulation of NKG2D Ligands in Cancer
por: Huergo-Zapico, Leticia, et al.
Publicado: (2014)

Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response
por: Baugh, Richard, et al.
Publicado: (2020)

Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
por: Jones, Amber B., et al.
Publicado: (2022)

Leveraging NKG2D Ligands in Immuno-Oncology
por: Fuertes, Mercedes Beatriz, et al.
Publicado: (2021)

Identification of small-molecule protein–protein interaction inhibitors for NKG2D
por: Thompson, Aaron A., et al.
Publicado: (2023)

Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications
por: Jimenez-Perez, Miriam I, et al.
Publicado: (2012)

Regulation of immune cell function and differentiation by the NKG2D receptor
por: Zafirova, Biljana, et al.
Publicado: (2011)

Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation
por: Vyas, Maulik, et al.
Publicado: (2017)

Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma
por: Wang, Jian, et al.
Publicado: (2020)

New twist on the regulation of NKG2D ligand expression
por: Cerwenka, Adelheid
Publicado: (2009)

New twist on the regulation of NKG2D ligand expression
por: Cerwenka, Adelheid
Publicado: (2009)

NKG2D ligands mediate immunosurveillance of senescent cells
por: Sagiv, Adi, et al.
Publicado: (2016)

MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome?
por: Risti, Matilde, et al.
Publicado: (2017)

ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
por: Zocchi, Maria Raffaella, et al.
Publicado: (2015)

Modulation of NKG2D, KIR2DL and Cytokine Production by Pleurotus ostreatus Glucan Enhances Natural Killer Cell Cytotoxicity Toward Cancer Cells
por: EL-Deeb, Nehal M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sg5ssgmhohoj2cntbv29bt5bed